Accelerated, scalable same-day microfluidic sequential gene editing for allogeneic cell therapy

Overview

Project Summary Allogeneic therapies hold significant promise as "off-the-shelf" treatments, offering faster and more accessible alternatives to autologous therapies. However, current allogeneic CAR-T manufacturing faces challenges in preventing immune rejection and alloreactivity. These challenges are particularly…